|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-7-10
|
|
pubmed:abstractText |
Several antipsychotic drugs are metabolised by the polymorphic cytochrome P(450) CYP2D6. The impact of the polymorphism on the plasma levels and the occurrence of side effects have not been clearly established.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0033-3158
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
162
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
67-73
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12107620-Adult,
pubmed-meshheading:12107620-Aged,
pubmed-meshheading:12107620-Analysis of Variance,
pubmed-meshheading:12107620-Chi-Square Distribution,
pubmed-meshheading:12107620-Clopenthixol,
pubmed-meshheading:12107620-Confidence Intervals,
pubmed-meshheading:12107620-Cytochrome P-450 CYP2D6,
pubmed-meshheading:12107620-Dyskinesia, Drug-Induced,
pubmed-meshheading:12107620-Female,
pubmed-meshheading:12107620-Humans,
pubmed-meshheading:12107620-Male,
pubmed-meshheading:12107620-Middle Aged,
pubmed-meshheading:12107620-Odds Ratio,
pubmed-meshheading:12107620-Parkinsonian Disorders,
pubmed-meshheading:12107620-Polymorphism, Genetic,
pubmed-meshheading:12107620-Regression Analysis,
pubmed-meshheading:12107620-Schizophrenia
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype.
|
|
pubmed:affiliation |
Department of Psychiatry, University of Tartu, 31 Raja St., 50417 Tartu, Estonia. Peeter.Jaanson@kliinikum.ee
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
